Atlas Trials

External Sensing and Neuromodulation to Assess Diabetic Pain Outcomes (XANADO)

Clinical trial NCT05537662 · UNKNOWN

Trial details

NCT number
NCT05537662
Sponsor
Abbott Medical Devices
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Chronic Pain
Start date
2023-06-06
Primary completion
2025-01-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.